Park Medi World Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 16.8%)
- Efficient capital deployment (ROCE 19.5%)
- Low debt relative to equity (D/E 0.2x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026 and other business matters
Latest News
All newsPark Medi World acquires wholly owned subsidiary
*Park Medi World acquires wholly owned subsidiary* The company completed the acquisition of its wholly owned subsidiary as part of internal restructuring. The move is expected to streamline operations and consolidate management. No financial details of the transaction were disclosed. 📊 *STOCKS:* $PARKHOSP | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Acquisition
Park Medi World announces board meeting outcome.
*Park Medi World announces board meeting outcome.* The company disclosed the outcome of its board meeting held on August 31, 2026. No major strategic decisions or financial announcements were revealed. The update is primarily procedural in nature. 📊 *STOCKS:* $PARKMED | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting
Park Medi World announces board meeting outcome
*Park Medi World announces outcome of recent board meeting.* The company disclosed key decisions taken during the August 03, 2026, meeting. Details include **no major financial announcements** or strategic shifts. The update is primarily procedural in nature. 📊 *STOCKS:* $PARKMEADOW | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #BoardMeeting
Park Medi World to acquire healthcare asset
*Park Medi World to acquire healthcare asset* — Park Medi World Limited has announced plans to acquire a healthcare project for **₹**. The acquisition aims to expand its footprint in the medical infrastructure sector. Financial terms were not fully disclosed. The move is expected to enhance long-term revenue streams. 📊 *STOCKS:* PARKINFRAPROJ | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #Acquisition
Park Medi World reports Q1 FY26 financial results.
*Park Medi World reports Q1 FY26 financial results.* The company has submitted its financial performance for the quarter ended June 30, 2026. Results reflect operational update for the first quarter with key metrics expected to influence near-term trading sentiment. Full details available in the corporate filing. 📊 *STOCKS:* $PARKME | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Earnings
Park Group of Hospitals reports Q1 FY27 unaudited results.
*Park Group of Hospitals reports Q1 FY27 unaudited results.* The company disclosed unaudited financial performance for the first quarter of FY27. Key metrics include revenue of **₹128 crore** and net profit of **₹18.2 crore**, showing **12% YoY growth** in profitability. Results reflect stable performance amid controlled operating expenses. 📊 *STOCKS:* PMWL | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Earnings
Park Medi World holds shareholder meeting, submits ballot report
*Park Medi World holds shareholder meeting, submits ballot report.* The company filed a scrutinizer's report on the postal ballot held on August 03, 2026. This routine corporate disclosure confirms procedural compliance. No immediate financial impact is indicated. 📊 *STOCKS:* $PARKMED | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ShareholdersMeeting
Park Medi World shares dividend date update
*Park Medi World shares dividend date update.* The company has filed the notice of AGM and annual report for FY 2025–2026 on the NSE. Details on dividend declaration and payment date are expected at the upcoming annual general meeting. Shareholders should monitor the official announcements for **record date** and **dividend per share**. 📊 *STOCKS:* $PARKMED | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Dividend
Park Medi World to hold shareholder meeting on Sep 22, 2026
*Park Medi World to hold shareholder meeting on Sep 22, 2026.* The company has scheduled the event for **11:00 a.m.** to discuss key corporate matters. This is a routine compliance and governance-related event. No financial announcements or strategic shifts were indicated in the filing. 📊 *STOCKS:* $PARKMED | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ShareholdersMeeting
Park Medi World shares rise 3% on capex update
*Park Medi World shares rise 3% on capex update.* The stock extended gains for a fifth straight session following news of increased capital expenditure plans. The healthcare player aims to expand its hospital network with **₹300 crore** capex over the next 18 months. Investors responded positively to the growth signal. 📊 *STOCKS:* $PARKINFR | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #capex
Financials
Quarterly Results
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹476 Cr 3.5% | ₹460 Cr 12.2% | ₹410 Cr 0.0% | ₹410 Cr 2.8% | ₹399 Cr 12.7% | ₹354 Cr 1.7% | ₹348 Cr |
| Op. Profit | ₹126 Cr 0.8% | ₹127 Cr 28.3% | ₹99 Cr 12.4% | ₹113 Cr 7.6% | ₹105 Cr 19.3% | ₹88 Cr 6.0% | ₹83 Cr |
| OPM | 26.0% 7.1% | 28.0% 16.7% | 24.0% 11.1% | 27.0% 3.8% | 26.0% 4.0% | 25.0% 4.2% | 24.0% |
| Net Profit | ₹89 Cr 15.6% | ₹77 Cr 45.3% | ₹53 Cr 32.9% | ₹79 Cr 19.7% | ₹66 Cr 26.9% | ₹52 Cr 13.0% | ₹46 Cr |
| EPS (₹) | 1.91 16.5% | 1.64 40.2% | 1.17 38.7% | 1.91 26.5% | 1.51 29.1% | 1.17 60.6% | 2.97 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹1.7K Cr 20.4% | ₹1.4K Cr 13.2% | ₹1.2K Cr 1.9% | ₹1.3K Cr 15.8% | ₹1.1K Cr 41.5% | ₹766 Cr |
| Expenses | ₹1.2K Cr 20.9% | ₹1.0K Cr 11.0% | ₹919 Cr 6.5% | ₹863 Cr 16.6% | ₹740 Cr 61.9% | ₹457 Cr |
| Op. Profit | ₹446 Cr 19.3% | ₹374 Cr 19.9% | ₹312 Cr 20.2% | ₹391 Cr 13.3% | ₹345 Cr 11.7% | ₹309 Cr |
| OPM | 27.0% 0.0% | 27.0% 8.0% | 25.0% 19.4% | 31.0% 3.1% | 32.0% 20.0% | 40.0% |
| Other Income | ₹32 Cr 6.7% | ₹30 Cr 3.4% | ₹29 Cr 93.3% | ₹15 Cr 66.7% | ₹9 Cr 200.0% | ₹3 Cr |
| Interest | ₹61 Cr 1.6% | ₹62 Cr 13.9% | ₹72 Cr 41.2% | ₹51 Cr 27.5% | ₹40 Cr 66.7% | ₹24 Cr |
| Depreciation | ₹62 Cr 8.8% | ₹57 Cr 11.8% | ₹51 Cr 24.4% | ₹41 Cr 17.1% | ₹35 Cr 45.8% | ₹24 Cr |
| PBT | ₹355 Cr 24.1% | ₹286 Cr 31.2% | ₹218 Cr 30.8% | ₹315 Cr 13.3% | ₹278 Cr 4.9% | ₹265 Cr |
| Tax % | 23.0% 8.0% | 25.0% 16.7% | 30.0% 7.1% | 28.0% 0.0% | 28.0% 7.7% | 26.0% |
| Net Profit | ₹274 Cr 27.4% | ₹215 Cr 41.4% | ₹152 Cr 33.3% | ₹228 Cr 14.6% | ₹199 Cr 6.4% | ₹187 Cr |
| EPS (₹) | 5.98 13.9% | 5.25 47.4% | 9.98 30.2% | 14.29 21.5% | 11.76 85.4% | 80.54 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Liabilities | ||||||
| Equity Capital | ₹86 Cr 11.7% | ₹77 Cr 0.0% | ₹77 Cr 0.0% | ₹77 Cr 0.0% | ₹77 Cr 305.3% | ₹19 Cr |
| Reserves | ₹1.9K Cr 98.6% | ₹975 Cr 21.0% | ₹806 Cr 32.1% | ₹610 Cr 60.5% | ₹380 Cr 48.4% | ₹256 Cr |
| Borrowings | ₹364 Cr 46.6% | ₹682 Cr 0.7% | ₹687 Cr 19.3% | ₹576 Cr 11.4% | ₹517 Cr 77.1% | ₹292 Cr |
| Other Liabilities | ₹411 Cr 4.6% | ₹393 Cr 14.6% | ₹343 Cr 3.6% | ₹331 Cr 3.8% | ₹319 Cr 28.1% | ₹249 Cr |
| Total Liabilities | ₹2.8K Cr 31.5% | ₹2.1K Cr 11.2% | ₹1.9K Cr 20.0% | ₹1.6K Cr 23.2% | ₹1.3K Cr 58.5% | ₹816 Cr |
Assets | ||||||
| Fixed Assets | ₹1.3K Cr 47.1% | ₹890 Cr 6.3% | ₹837 Cr 56.2% | ₹536 Cr 17.0% | ₹458 Cr 25.5% | ₹365 Cr |
| CWIP | ₹123 Cr 232.4% | ₹37 Cr 15.6% | ₹32 Cr 540.0% | ₹5 Cr 82.8% | ₹29 Cr 314.3% | ₹7 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹1.4K Cr 13.8% | ₹1.2K Cr 15.0% | ₹1.0K Cr 0.9% | ₹1.1K Cr 30.5% | ₹806 Cr 81.9% | ₹443 Cr |
| Total Assets | ₹2.8K Cr 31.5% | ₹2.1K Cr 11.2% | ₹1.9K Cr 20.0% | ₹1.6K Cr 23.2% | ₹1.3K Cr 58.5% | ₹816 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Operating CF | ₹329 Cr 53.0% | ₹215 Cr 41.4% | ₹367 Cr 84.4% | ₹199 Cr 28.4% | ₹155 Cr 30.5% | ₹223 Cr |
| Investing CF | ₹-316 Cr 216.0% | ₹-100 Cr 31.6% | ₹-76 Cr 67.5% | ₹-234 Cr 5.6% | ₹-248 Cr 6.4% | ₹-233 Cr |
| Financing CF | ₹121 Cr 236.0% | ₹-89 Cr 31.5% | ₹-130 Cr 13100.0% | ₹1 Cr 99.4% | ₹163 Cr 232.7% | ₹49 Cr |
| Net Cash Flow | ₹134 Cr 415.4% | ₹26 Cr 83.9% | ₹161 Cr 573.5% | ₹-34 Cr 148.6% | ₹70 Cr 79.5% | ₹39 Cr |
| Free Cash Flow | ₹209 Cr 198.6% | ₹70 Cr 76.6% | ₹299 Cr 182.1% | ₹106 Cr 65.6% | ₹64 Cr 25.6% | ₹86 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Debtor Days | 129d 19.9% | 161d 6.6% | 151d 10.1% | 168d 11.3% | 151d 0.0% | 151d |
| Inventory Days | 4d 33.3% | 3d 0.0% | 3d 0.0% | 3d 78.6% | 14d 70.2% | 47d |
| Days Payable | 134d 23.9% | 176d 32.3% | 133d 20.9% | 110d 8.9% | 101d 16.5% | 121d |
| Cash Conv. Cycle | -2d 83.3% | -12d 157.1% | 21d 65.6% | 61d 4.7% | 64d 16.9% | 77d |
| Working Capital Days | 28d 6.7% | 30d 42.9% | 21d 47.5% | 40d 33.3% | 60d 50.0% | 40d |
| ROCE | 19.0% 5.0% | 20.0% 0.0% | 20.0% 35.5% | 31.0% 18.4% | 38.0% | — |
Source: Screener.in · Lower days = better efficiency